Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision BioSpaceThe company is investing billions of dollars to construct a European biosimilar hub capable of supporting the rapid expansion of its portfolio.Read full story pharminent September 9, 2026 (Last updated: September 10, 2026) BioSpace The company is investing billions of dollars to construct a European biosimilar hub capable of supporting the rapid expansion of its portfolio. Read full story Post navigation Previous: Novartis’s Del-Desiran Misses Primary Endpoint in HARBOR, Putting the $12B Avidity Deal Under ScrutinyNext: FDA Names Permanent CDER and CBER Directors While the Commissioner’s Post Awaits Confirmation Related Stories Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026 Manufacturing Multispecifics are transforming the CDMO development architecture pharminent August 28, 2026 Manufacturing Roche commits $750m to double Oregon-based US manufacturing capacity pharminent August 21, 2026